Immunosuppression with FK506 increases bone induction in demineralized isogeneic and xenogeneic bone matrix in the rat

被引:30
|
作者
Voggenreiter, G [1 ]
Assenmacher, S
Kreuzfelder, E
Wolf, M
Kim, MR
Nast-Kolb, D
Schade, FU
机构
[1] Univ Essen Gesamthsch, Dept Trauma Surg, D-45122 Essen, Germany
[2] Univ Hosp Essen, Clin Res Grp Shock & Multi Organ Failure, Essen, Germany
[3] Univ Hosp Essen, Inst Immunol, Essen, Germany
关键词
immunosuppression; osteoinduction; T lymphocytes; bone histomorphometry; demineralized bone matrix;
D O I
10.1359/jbmr.2000.15.9.1825
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present study was to investigate a systemic induction of bone formation in rats by immunosuppression with FK506 (1 mg/kg body weight intraperitoneally [ip]) in a model of osteoinduction of isogeneic and xenogeneic demineralized bone matrix (DBM) for a period of 28 days. In particular, alterations of in vitro cytokine synthesis and changes of lymphocyte subsets were studied. DBM was implanted intramuscularly in the abdominal wad of Lewis rats (seven per group). Blood was sampled on days -7, 0, 7, and 28 for determination of in vitro tumor necrosis factor alpha (TNF-alpha) synthesis and lymphocyte subsets by flow cytometry (CD3+, CD4+, CD8+, CD45+, ED9+, and Ia+ antibodies). Ossicles of de novo formed bone and the tibias were removed on day 28 after double tetracycline labeling for histomorphometric analysis. Immunosuppression with FK506 significantly decreased lipopolysaccharide (LPS)-stimulated in vitro cytokine synthesis after 7 days and 28 days (p < 0.05). Compared with control animals FK506 treatment significantly increased the volume of induced bone in isogeneic (2.1 +/- 0.3 mm(3) vs. 10.8 +/- 0.9 mm(3)) and xenogeneic (0 mm(3) vs. 4.7 +/- 0.8 mm(3)) DBM. Bone histomorphometry of the tibias revealed that immunosuppression increased both bone formation and bone resorption, accompanied by a significant reduction in the relative trabecular area (Tb.Ar). FK506 caused a decrease in the counts of CD8+ T cells probably because of destruction or dislocation of these cells. This suggests that the amount of CD8+ cells and the degree of T cell activation in terms of mean fluorescence intensity (MFI) may be associated with bone metabolism. In support of this, statistical analysis revealed a significant positive correlation between parameters of bone formation as well as bone resorption and the CD4+/CD8+ ratio. There was a significant negative correlation between parameters of remodeling of the metaphysis of the tibia and induced bone volume (BV), respectively, and MFI values of CD3+/Ia+ cells. These findings suggest an important role of T lymphocytes in bone formation and bone resorption in vivo. FK506 caused a marked increase of bone formation in DBM. However, the conclusion that immunosuppression increases fracture healing warrants further investigation.
引用
收藏
页码:1825 / 1834
页数:10
相关论文
共 50 条
  • [1] FK506 IN BONE-MARROW TRANSPLANTATION
    HEMENWAY, C
    BLOOD, 1995, 86 (09) : 3611 - 3612
  • [2] Immunosuppression with FK506 has no influence on fracture healing in the rat
    Voggenreiter, G
    Siozos, P
    Hunkemöller, E
    Heute, S
    Schwarz, M
    Obertacke, U
    BONE, 2005, 37 (02) : 227 - 233
  • [3] Tacrolimus, FK506, promotes bone formation in bone defect mouse model
    Nishida, Satoko
    Azetsu, Yuki
    Chatani, Masahiro
    Karakawa, Akiko
    Otake, Kai
    Sugiki, Hidemitsu
    Sakai, Nobuhiro
    Maruoka, Yasubumi
    Myers, Mie
    Takami, Masamichi
    JOURNAL OF ORAL BIOSCIENCES, 2024, 66 (02) : 391 - 402
  • [4] Rapid trabecular bone loss after cardiac transplantation using FK506 (tacrolimus)-based immunosuppression
    Stempfle, HU
    Werner, C
    Echtler, S
    Assum, T
    Meiser, B
    Angermann, CE
    Theisen, K
    Gärtner, R
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1132 - 1133
  • [6] Inhibition of iNOS induction by FK506, but not by cyclosporine, in rat hepatocytes
    Kaibori, M
    Okumura, T
    Ito, S
    Oda, M
    Inoue, T
    Kamiyama, Y
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 804 - 805
  • [7] Bone marrow hypoplasia complicating tacrolimus (FK506) therapy
    Nosari, A
    Marbello, L
    De Carlis, LG
    De Gasperi, A
    Muti, G
    Mancini, V
    Morra, E
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (02) : 130 - 132
  • [8] Regulation of bone metabolism in immunosuppressant (FK506)-treated rats
    Kirino, S
    Fukunaga, J
    Ikegami, S
    Tsuboi, H
    Kimata, M
    Nakata, N
    Nakano, M
    Ueno, T
    Mizukawa, N
    Sugahara, T
    JOURNAL OF BONE AND MINERAL METABOLISM, 2004, 22 (06) : 554 - 560
  • [9] Correlation of FK506 and bone metabolism in male kidney recipients
    Luo, L.
    Shi, Y.
    Li, Y.
    Tang, J.
    Bai, Y.
    Cai, B.
    Yan, L.
    Zou, Y.
    Wang, L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1480 - 1481
  • [10] Bone marrow hypoplasia complicating tacrolimus (FK506) therapy
    Annamaria Nosari
    Laura Marbello
    Luciano G. De Carlis
    Andrea De Gasperi
    Giuliana Muti
    Valentina Mancini
    Enrica Morra
    International Journal of Hematology, 2004, 79 : 130 - 132